ES2119552T3 - Derivados de ciclodextrina. - Google Patents

Derivados de ciclodextrina.

Info

Publication number
ES2119552T3
ES2119552T3 ES96402446T ES96402446T ES2119552T3 ES 2119552 T3 ES2119552 T3 ES 2119552T3 ES 96402446 T ES96402446 T ES 96402446T ES 96402446 T ES96402446 T ES 96402446T ES 2119552 T3 ES2119552 T3 ES 2119552T3
Authority
ES
Spain
Prior art keywords
sub
cyclodextrin derivatives
compounds
refers
hydroxialkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96402446T
Other languages
English (en)
Inventor
Herve Richard
Madeleine Leduc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2119552T3 publication Critical patent/ES2119552T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/738Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS DERIVADOS DE CICLODEXTRINA DE FORMULA (I) CD(OH){SUB,L}(OR{SUB,1}){SUB,M})(OR{SUB,2}){SUB,N} EN LA QUE OR{SUB,1} REPRESENTA UN GRUPO FILTRANTE O ANTIOXIDANTE O SU MEZCLA, OR{SUB,2} REPRESENTA UN RADICAL ALQUILO O HIDROXIALQUILO, L, M Y N SON VALORES ESTADISTICOS. LA INVENCION SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION DE ESTOS COMPUESTOS Y A LA UTILIZACION DE ESTOS COMPUESTOS EN COSMETICA.
ES96402446T 1995-12-04 1996-11-14 Derivados de ciclodextrina. Expired - Lifetime ES2119552T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514318A FR2741882B1 (fr) 1995-12-04 1995-12-04 Nouveaux derives de cyclodextrine

Publications (1)

Publication Number Publication Date
ES2119552T3 true ES2119552T3 (es) 1998-10-01

Family

ID=9485129

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96402446T Expired - Lifetime ES2119552T3 (es) 1995-12-04 1996-11-14 Derivados de ciclodextrina.

Country Status (7)

Country Link
US (1) US6045812A (es)
EP (1) EP0778287B1 (es)
JP (1) JP3178846B2 (es)
DE (1) DE69600292T2 (es)
ES (1) ES2119552T3 (es)
FR (1) FR2741882B1 (es)
WO (1) WO1997020861A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19718318A1 (de) * 1997-04-30 1998-11-05 Beiersdorf Ag Wirkstoffkombinationen bzw. Addukte aus Dibenzoylmethanderivaten und/oder Zimtsäurederivaten und Cyclodextrinen und Verwendung solcher Wirkstoffkombinationen in kosmetischen Lichtschutzzubereitungen
FR2808691B1 (fr) * 2000-05-12 2005-06-24 Coletica Cyclodextrines substituees preferentiellement sur leur face primaire par des fonctions acide ou amine
FR2840531B1 (fr) * 2002-06-11 2004-10-29 Oreal Composition cosmetique comprenant un agent mimetique de l'activite de la dopachrome tautomerase (trp-2) pour lutter contre la canitie
WO2003103616A2 (fr) 2002-06-11 2003-12-18 L'oreal Utilisation d'un agent mimetique de l'activite de la dopachrome tautomerase (trp-2) comme agent protecteur des melanocytes du follicule pileux et applications
DE10230970A1 (de) * 2002-07-10 2004-01-22 Beiersdorf Ag Schützender Haarfestiger
US7166671B2 (en) * 2002-12-10 2007-01-23 Cellresin Technologies, Llc Grafted cyclodextrin
US7385004B2 (en) * 2002-12-10 2008-06-10 Cellresin Technologies, Llc Enhanced lubrication in polyolefin closure with polyolefin grafted cyclodextrin
US8129450B2 (en) 2002-12-10 2012-03-06 Cellresin Technologies, Llc Articles having a polymer grafted cyclodextrin
JP4908405B2 (ja) * 2004-05-24 2012-04-04 セルレジン・テクノロジーズ・エルエルシー 熱可塑性ポリマー組成物、フィルム、ファイバー、ファブリック
GB0808479D0 (en) * 2008-05-09 2008-06-18 Uni I Oslo Topical compositions
BR102013007969A2 (pt) * 2013-04-03 2014-11-11 Isp Do Brasil Ltda Composições cosméticas e uso de ciclodextrina
EP3290026A1 (en) 2016-09-06 2018-03-07 Athenion AG Method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents
EP3421096A1 (en) 2017-06-30 2019-01-02 Athenion AG Method for solubilizing poorly water-soluble cosmetic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU616571B2 (en) * 1988-10-28 1991-10-31 Shiseido Company Ltd. Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin

Also Published As

Publication number Publication date
DE69600292D1 (de) 1998-06-18
FR2741882B1 (fr) 1998-01-09
WO1997020861A1 (fr) 1997-06-12
EP0778287B1 (fr) 1998-05-13
JPH10505632A (ja) 1998-06-02
US6045812A (en) 2000-04-04
EP0778287A1 (fr) 1997-06-11
FR2741882A1 (fr) 1997-06-06
JP3178846B2 (ja) 2001-06-25
DE69600292T2 (de) 1998-09-03

Similar Documents

Publication Publication Date Title
ES2119552T3 (es) Derivados de ciclodextrina.
HUP9801240A2 (en) Oral compositions
ES2143187T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
BR9911783A (pt) Compostos cìclicos substituìdos, processo para sua preparação e composições farmacêuticas que os contêm
BR9914814A (pt) Processo para a preparação de luteolina e derivados de luteolina
BG104247A (en) Resorcinol derivatives
ES2089822T3 (es) Polimeros para productos cosmeticos y de cuidado personal.
BG102172A (en) New stable medicamentous compositions for the preparation of propellant-free aerosols
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
ES2105551T3 (es) Utilizacion de derivados de la resorcina substituidos en posicion(es) 4,4 y 5 o 4 y 6 en unas composiciones cosmeticas o dermofarmaceuticas con accion despigmentante.
FI793688A (fi) Hydroxipropyl-triazol foerfarande foer framstaellning av dem och deras anvaendning som laekemedel
ES2142512T3 (es) Nuevas substancias odoriferas.
ES2148758T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
FI792939A (fi) Fluorhaltiga 1,4-dihydropyridiner foerfarande foer framstaellning av dem och deras anvaendning som laekemedel
BR9805031A (pt) Compostos de naftaleno, processo para sua preparação e composições farmacêuticas contendo os mesmos.
ES2112670T3 (es) Derivados de ciclodextrina y su utilizacion, particularmente en cosmetica.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
HUP9802206A1 (hu) Thalidomid intravénás adagolási formája immunológiai megbetegedések gyógyításához
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
ES2161446T3 (es) Taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ATE201204T1 (de) Derivate der thiazolidine-4-carbonsäure als cytoprotektive mittel
ES2148458T3 (es) Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DK1107776T3 (da) Tørekstrakt af hennaplante, fremgangsmåde til fremstilling heraf og anvendelse heraf
FR2645145B1 (fr) Compositions cosmetiques et pharmaceutiques contenant des derives lipophiles du benzylidene camphre et nouveaux derives lipophiles du benzylidene camphre

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 778287

Country of ref document: ES